Suppr超能文献

欧洲癌症与营养前瞻性调查队列研究(EPIC):罕见癌症流行病学研究的途径

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research.

作者信息

Fernandez-Cuesta L, Voegele C, Hemon B, Alcala K, Aune D, Caini S, Casalone E, Cross A J, Ferrari P, Girard N, Katzke V, van Leeuwaarde R S, Matullo G, Melin B, Murphy G, Viallon V, Walter T, Gunter M J, Trama A, Alcala N, Foll M

机构信息

Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

出版信息

ESMO Rare Cancers. 2025 Jun;2:None. doi: 10.1016/j.esmorc.2025.100014.

Abstract

BACKGROUND

The intrinsic limitations of studying rare cancers poses challenges to undertaking studies with adequate statistical power. Therefore, efforts are needed to exploit available, high-quality resources. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a large-scale longitudinal cohort with great potential for rare cancer research.

MATERIALS AND METHODS

We have used the EPIC data, which includes lifestyle, diet, and health information, on ∼520  000 participants recruited across Europe. Rare cancers were identified according to the RARE CAncer REgistry network (RARECAREnet) classification, which includes incidence-based categorization and detailed morphological and site-specific information.

RESULTS

An interactive R Shiny web application was developed to explore EPIC data interactively, available at https://epic-rare-cancers-explorer.opendata.iarc.who.int. Among the EPIC participants, 11 450 incident cases of rare cancers were identified, with data currently available for 8851 of them, encompassing a wide range of cancer sites and morphologies. Sex ratios and incidence rates align with previously reported statistics. The R Shiny web application was designed for preliminary data analysis and hypothesis generation, aiding researchers in assessing the feasibility and potential of epidemiological studies. Taking head and neck cancers as a use case, we confirmed the strong association of these tumors with tobacco and alcohol consumption, proving the suitability of EPIC for identifying risk factors for rare cancers. However, it is important to note that, as with all observational studies, the associations reported in this article do not establish causality.

CONCLUSION

The development of the EPIC rare cancers database, accompanied by the development of an interactive web application, represents a significant step forward in rare cancer research embedded within a large-scale population-based cohort. It is therefore vital to promote awareness of this resource within the research community.

摘要

背景

研究罕见癌症存在内在局限性,这给开展具有足够统计效力的研究带来了挑战。因此,需要努力利用现有的高质量资源。欧洲癌症与营养前瞻性调查(EPIC)是一个大规模纵向队列,在罕见癌症研究方面具有巨大潜力。

材料与方法

我们使用了EPIC数据,该数据包含了欧洲各地招募的约520,000名参与者的生活方式、饮食和健康信息。根据罕见癌症登记网络(RARECAREnet)分类来识别罕见癌症,该分类包括基于发病率的分类以及详细的形态学和特定部位信息。

结果

开发了一个交互式R Shiny网络应用程序,可通过https://epic-rare-cancers-explorer.opendata.iarc.who.int交互式地探索EPIC数据。在EPIC参与者中,识别出11450例罕见癌症病例,目前有8851例的数据可用,涵盖了广泛的癌症部位和形态。性别比和发病率与先前报告的统计数据一致。R Shiny网络应用程序旨在进行初步数据分析和假设生成,帮助研究人员评估流行病学研究的可行性和潜力。以头颈癌为例,我们证实了这些肿瘤与烟草和酒精消费之间的强关联,证明了EPIC在识别罕见癌症风险因素方面的适用性。然而,需要注意的是,与所有观察性研究一样,本文报告的关联并不能确立因果关系。

结论

EPIC罕见癌症数据库的开发,以及交互式网络应用程序的开发,代表了在大规模人群队列中开展的罕见癌症研究向前迈出的重要一步。因此,在研究界提高对这一资源的认识至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a709/12257713/9ba96c7eaf0d/gr1.jpg

相似文献

2
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study.
Eur J Cancer. 2025 Jan;214:115147. doi: 10.1016/j.ejca.2024.115147. Epub 2024 Nov 27.
3
An integrated cell atlas of the lung in health and disease.
Nat Med. 2023 Jun;29(6):1563-1577. doi: 10.1038/s41591-023-02327-2. Epub 2023 Jun 8.
4
'Rare cancers': not all together in clinical studies!
Ann Oncol. 2022 May;33(5):463-465. doi: 10.1016/j.annonc.2022.01.077. Epub 2022 Feb 4.
7
Incidence and survival of rare cancers in the US and Europe.
Cancer Med. 2020 Aug;9(15):5632-5642. doi: 10.1002/cam4.3137. Epub 2020 May 21.
9
Alcohol and Cancer: A Statement of the American Society of Clinical Oncology.
J Clin Oncol. 2018 Jan 1;36(1):83-93. doi: 10.1200/JCO.2017.76.1155. Epub 2017 Nov 7.
10
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验